Company Profile

Epivara (AKA: Insigna Inc)
Profile last edited on: 10/31/2022      CAGE: 8BNA4      UEI: JGXWKCJNGZ15

Business Identifier: Injectable spay/neuter solution for animals
Year Founded
2019
First Award
2021
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

60 Hazelwood Drive Suite 230G
Champaign, IL 61820
   (217) 200-6485
   hello@epivara.com
   www.epivara.com
Location: Single
Congr. District: 13
County: Champaign

Public Profile

Epivara - formerly known as Insigna Inc and spun out of University of Illinois - develops a new method to spay/neuter animals using a single injection. This solution decreases surgery risks, lowers the cost, and is easier to administer for organizations and shelters. The solution also has benefits for the animals through minimizing discomfort, 100% success, the ability to spay/neuter homeless animals without transporting them, and no recovery time needed. The spot, EpiFix, costs less than surgery and is a tiny pellet the size of a grain of rice.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 1 USDA $175,000
Project Title: Single injection alternative to surgical castration in pigs
2021 1 NSF $254,760
Project Title: Safe and effective injectable alternative to surgical spays in female dogs

Key People / Management

  Chemyong Jay Ko -- Founder, CEO, Chairman of the Board

  Eui Yui Choi -- Board member

  Eui Yui Choi -- Board member

  Rex Hess -- Director of Science

  Chan Jin Park -- Vice President of Research